ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 91 filers reported holding ENDOCYTE INC in Q1 2018. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 100 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
| Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
| PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
| Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
| Leisure Capital Management | 28,304 | $121,000 | 0.10% |
| Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
| EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
| SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
| Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
| Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |